These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 23909527
1. Renal sympathetic nerve denervation for the treatment of resistant hypertension. Palmer SC, Judkins C, Williams PD, Whitbourn RJ. Med J Aust; 2013 Aug 05; 199(3):160-2. PubMed ID: 23909527 [Abstract] [Full Text] [Related]
2. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension. Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD, Schlaich MP. Int J Cardiol; 2016 Jan 01; 202():388-93. PubMed ID: 26432488 [Abstract] [Full Text] [Related]
3. Expanding the indication spectrum: renal denervation in diabetes. Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Böhm M. EuroIntervention; 2013 May 01; 9 Suppl R():R117-21. PubMed ID: 23732142 [Abstract] [Full Text] [Related]
4. Response and non-response to renal denervation: who is the ideal candidate? Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F. EuroIntervention; 2013 May 01; 9 Suppl R():R54-7. PubMed ID: 23732156 [Abstract] [Full Text] [Related]
5. Catheter-based renal denervation for treatment of hypertension. Azizi M. Lancet; 2017 Nov 11; 390(10108):2124-2126. PubMed ID: 28859945 [No Abstract] [Full Text] [Related]
6. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension. Schlaich MP. Am J Hypertens; 2017 Sep 01; 30(9):847-856. PubMed ID: 28338871 [Abstract] [Full Text] [Related]
7. Current Status of Renal Denervation in Hypertension. Briasoulis A, Bakris GL. Curr Cardiol Rep; 2016 Nov 01; 18(11):107. PubMed ID: 27614466 [Abstract] [Full Text] [Related]
9. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M. Clin Res Cardiol; 2016 Apr 01; 105(4):364-71. PubMed ID: 26493305 [Abstract] [Full Text] [Related]
10. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go? Briasoulis A, Bakris G. Can J Cardiol; 2015 May 01; 31(5):642-8. PubMed ID: 25828371 [Abstract] [Full Text] [Related]
11. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"? Laffin LJ, Bakris GL. Am J Hypertens; 2017 Sep 01; 30(9):841-846. PubMed ID: 27838622 [Abstract] [Full Text] [Related]
12. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence. Persu A, Renkin J, Asayama K, O'Brien E, Staessen JA. Expert Rev Cardiovasc Ther; 2013 Jun 01; 11(6):739-49. PubMed ID: 23750683 [Abstract] [Full Text] [Related]
13. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium. Blood Press; 2015 Jun 01; 24(5):263-74. PubMed ID: 26194721 [Abstract] [Full Text] [Related]
15. Renal denervation: a potential new treatment for severe hypertension. Huan Y, Cohen DL. Clin Cardiol; 2013 Jan 01; 36(1):10-4. PubMed ID: 23124953 [Abstract] [Full Text] [Related]
16. Follow-up, study design and outcome parameters. Volpe M, Battistoni A, Tocci G. EuroIntervention; 2013 May 01; 9 Suppl R():R96-100. PubMed ID: 23732163 [Abstract] [Full Text] [Related]
17. Renal denervation: a plea for wisdom. Lantelme P, Courand PY, Pathak A. Arch Cardiovasc Dis; 2013 Mar 01; 106(3):121-3. PubMed ID: 23582673 [No Abstract] [Full Text] [Related]
18. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects. Kjeldsen SE, Os I, Mahfoud F. EuroIntervention; 2013 May 01; 9 Suppl R():R7-9. PubMed ID: 23732159 [No Abstract] [Full Text] [Related]
19. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD. Int J Cardiol; 2013 Oct 03; 168(3):2214-20. PubMed ID: 23453868 [Abstract] [Full Text] [Related]
20. Renal denervation for resistant hypertension: yes. Boschetti E, Alrashdi Y, Schillaci G. Intern Emerg Med; 2016 Jun 03; 11(4):491-3. PubMed ID: 26970989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]